Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus
Open Access
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 30 (4) , 1037-1044
- https://doi.org/10.1002/hep.510300403
Abstract
How Hepatitis C Virus (HCV) causes persistent infection is unknown. One hypothesis is that HCV evades the host immune response through mutation in immune epitopes. We have investigated mutations in the HCV genome to see if they cluster within immune epitopes; and we have studied the effect of antibody deficiency on mutation rates. We studied patients with chronic hepatitis C, 3 with antibody deficiency and 3 with normal immunity. Regions of the core and envelope genes of HCV, encoding cytotoxic (CTL), and B cell epitopes were sequenced at 2 time points, 2 years apart. The diversity of quasispecies increased with time. The HCV genetic mutation rate was higher than previously predicted. The cryptic nucleotide mutation rate in core was similar to that observed in envelope, suggesting that the error rate of the HCV RNA polymerase is similar in both regions. In contrast, the coding mutation rate was decreased in core and increased in envelope. No genetic mutation was seen in any of the core CTL epitopes despite detectable cellular responses. All patients had mutations within a previously described envelope CTL epitope but did not exhibit immune responses to either index or mutated peptides. There was no difference in mutation rates in any cellular or humoral epitopes between patients with antibody deficiency and normal immunity. Thus we have found no evidence that mutations were selected by T-lymphocytes or antibodies. These findings implicate alternative virus-host interactions in the selection of HCV mutations.Keywords
This publication has 46 references indexed in Scilit:
- Hepatitis C Virus Core Protein Interacts with Heterogeneous Nuclear Ribonucleoprotein KJournal of Biological Chemistry, 1998
- Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patientsHepatology, 1998
- Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core proteinVirus Research, 1995
- Detailed motifs for peptide binding to HLA-A∗0201 derived from large random sets of peptides using a cellular binding assayHuman Immunology, 1995
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- Comprehensive, serologically equivalent DNA typing for HLA‐B by PCR using sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- Hepatic Encephalopathy in the Age of TipsHepatology, 1994
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993
- Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1Science, 1990
- Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunityNature, 1983